Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 14)

In this week’s View, Dr. Eagle discuses hypertension management in patients with cardiovascular comorbidities, then looks at a patient-level analysis of Phase III trials that examines Inclisiran and cardiovascular events. Finally, Dr. Eagle explores the STROKESTOP study on the cost-effectiveness of population screening for atrial fibrillation.

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiovascular Care Team, Dyslipidemia, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Lipid Metabolism, Nonstatins, Novel Agents, Primary Hyperlipidemia, Statins, Sleep Apnea, Prevention, Valvular Heart Disease

Keywords: EaglesEyeView, Blood Pressure, Risk Reduction Behavior, Dementia, Stroke, Mental Status and Dementia Tests, Diabetes Mellitus, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocardial Infarction, Hyperlipoproteinemia Type II, Heart Arrest, Atrial Fibrillation, Cost-Benefit Analysis, Hemorrhagic Stroke, Electrocardiography, Risk Factors, Anticoagulants

< Back to Listings